Spontaneously transformed NRK cells lose their mitogenic response to epidermal growth factor

R J Wegrzyn1, D Defeo-Jones, D C Heimbrook

  • 1Department of Cancer Research, Merck Sharp and Dohme Research Laboratories, West Point, Pennsylvania 19486.

Insights

Spontaneously transformed NRK cells lose their growth factor-induced DNA synthesis response. This study investigates the link between cell transformation and epidermal growth factor (EGF) signaling.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Epidermal growth factor (EGF) is crucial for cell proliferation and survival.
  • Cell transformation involves changes in cell morphology and growth properties.
  • Understanding the interplay between growth factor signaling and cell transformation is vital for cancer research.

Purpose of the Study:

  • To investigate the relationship between growth factor-induced mitogenesis and spontaneous cell transformation.
  • To characterize EGF-responsive and nonresponsive NRK cell lines.
  • To determine the impact of cell transformation on EGF signaling pathways.

Main Methods:

  • Isolation and characterization of EGF-responsive (Cl-3) and EGF-nonresponsive (Cl-10) NRK cell subclones.
  • Assessment of cell morphology, growth in soft agar, and tumor formation in nude mice.
  • Measurement of DNA synthesis in response to EGF.
  • Analysis of EGF receptor number and binding affinity.

Main Results:

  • EGF-nonresponsive Cl-10 cells exhibited hallmarks of transformation, including altered morphology, enhanced anchorage-independent growth, and increased tumor formation.
  • Cl-3 cells showed a significant increase in DNA synthesis upon EGF stimulation, while Cl-10 cells did not.
  • Both cell lines possessed similar numbers of EGF receptors with comparable binding affinities.
  • No evidence of transforming growth factor-alpha was detected.

Conclusions:

  • Spontaneous morphologic transformation in NRK cells leads to a loss of mitogenic response to EGF.
  • EGF signaling pathways are altered during cell transformation, independent of receptor number or affinity.
  • These findings highlight a dissociation between EGF receptor expression and downstream signaling in transformed cells.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...